Topics

New Phase 3 data confirms safety and efficacy of UCB's Cimzia in plaque and psoriatic #arthritis http://bit.ly/2UK9wrq  #pharmapic.twitter.com/G4By55mxR5

06:39 EDT 30 Apr 2019 | Pharmafile

New Phase 3 data confirms safety and efficacy of UCB's Cimzia in plaque and psoriatic http://bit.ly/2UK9wrq 

Original Article: New Phase 3 data confirms safety and efficacy of UCB's Cimzia in plaque and psoriatic #arthritis http://bit.ly/2UK9wrq  #pharmapic.twitter.com/G4By55mxR5

NEXT ARTICLE

More From BioPortfolio on "New Phase 3 data confirms safety and efficacy of UCB's Cimzia in plaque and psoriatic #arthritis http://bit.ly/2UK9wrq  #pharmapic.twitter.com/G4By55mxR5"

Quick Search